Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
52.43
+0.82 (+1.58%)
Streaming Delayed Price
Updated: 12:46 PM EST, Dec 24, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
16,723,349
Open
52.85
Bid (Size)
52.42 (100)
Ask (Size)
52.43 (900)
Prev. Close
51.61
Today's Range
52.00 - 53.63
52wk Range
43.08 - 93.80
Shares Outstanding
N/A
Dividend Yield
4.19%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Weight of Innovation: Eli Lilly’s Dominance in the GLP-1 Era
Today 10:01 EST
Date: December 24, 2025By: Financial Research Insights Introduction As 2025 draws to a close, few companies have dominated the financial and medical headlines as consistently as Eli Lilly and Company...
Via
PredictStreet
Topics
Economy
Novo Nordisk (NVO) Research: The Oral Wegovy Pivot and the 2026 Outlook
Today 9:32 EST
As of December 24, 2025, the pharmaceutical landscape is witnessing a pivotal shift in the treatment of chronic obesity. Novo Nordisk (NYSE: NVO), the Danish titan that pioneered the GLP-1 revolution,...
Via
PredictStreet
Topics
Economy
Intellectual Property
Performance
YTD
-40.1%
-40.1%
1 Month
+16.6%
+16.6%
3 Month
-11.9%
-11.9%
6 Month
-25.9%
-25.9%
1 Year
-40.9%
-40.9%
More News
Read More
Hims & Hers Hit A GLP-1 Speed Bump This Year — But Growth Is Just Cooling, Not Cracking
↗
Today 9:16 EST
Via
Stocktwits
Novo Nordisk, Trinity Biotech, Starfighters Space, VisionWave, ServiceNow: Stocks Making The Biggest Moves Today
↗
December 23, 2025
Via
Stocktwits
Novo Nordisk’s Worst Year In Over Four Decades May Be Ending — Thanks To A Weight-Loss Pill
↗
December 23, 2025
Via
Stocktwits
Novo Nordisk A/S-Spons ADR (NYSE:NVO): A Prime Candidate for Steady Dividend Income
↗
Today 6:42 EST
Via
Chartmill
Stock Market Today, Dec. 23: U.S. Stocks Hold Near Records on Narrow Tech-Led Gains
↗
December 23, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Stocks
Why Novo Nordisk Stock Popped Today
↗
December 23, 2025
Via
The Motley Fool
Novo Nordisk Stock Soars as "Wegovy Pill" Gains FDA Approval, Reshaping Obesity Market
December 23, 2025
Via
MarketMinute
Stock Market Today, Dec. 23: Novo Nordisk Surges After FDA Approves Oral Wegovy Weight Loss Pill
↗
December 23, 2025
Via
The Motley Fool
Topics
Stocks
Novo Nordisk Breaks the Mold: Oral Obesity Breakthrough Sends Shares to New Heights as Pharma Landscape Shifts
December 23, 2025
Via
MarketMinute
Topics
Economy
Which stocks are most active on Tuesday?
↗
December 23, 2025
Via
Chartmill
Thin Trading and High Hopes: Markets Eye a 'Santa Claus Rally' as 2025 Draws to a Close
December 23, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Santa Claus Rally Solidifies as S&P 500 Secures Third Consecutive Winning Session Amid Economic Resilience
December 23, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
These stocks are gapping in today's session
↗
December 23, 2025
Via
Chartmill
The Great Biotech Rebound: How Pricing Clarity Rescued the Drug Sector in 2025
December 23, 2025
Via
MarketMinute
Topics
Economy
Nasdaq, S&P 500 Futures Tread Caution Ahead Of GDP, Confidence Data: Why NVO, ZIM, SIDU Are On Traders' Radar Today
↗
December 23, 2025
Via
Stocktwits
Topics
Stocks
Novo Nordisk Stock Soars After Hours As FDA Greenlights Wegovy Pill For Weight Loss
↗
December 22, 2025
Via
Stocktwits
The Incretin Empire: Eli Lilly’s (LLY) Path to a $1 Trillion Market Cap and Beyond
December 22, 2025
Via
PredictStreet
Topics
Economy
Intellectual Property
The Pfizer Pivot: A Deep-Dive into PFE’s 2025 Financial Recovery and Strategic Rebirth
December 22, 2025
Via
PredictStreet
Topics
Economy
Intellectual Property
Should You Forget Novo Nordisk and Buy This Magnificent High-Yield Drug Stock Instead?
↗
December 22, 2025
Via
The Motley Fool
Novo Nordisk (NYSE:NVO) Identified as a 'Decent Value' Stock with Strong Fundamentals
↗
December 20, 2025
Via
Chartmill
2026 Market Outlook: Key Themes and Predictions
December 19, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
Prediction: 1 Healthcare Giant Set to Soar in 2026
↗
December 18, 2025
Via
The Motley Fool
Topics
ETFs
The Weight of a Trillion: Inside Eli Lilly’s Pharmaceutical Hegemony
December 18, 2025
Via
PredictStreet
Topics
Economy
World Trade
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 52.43
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 12/24/25 12:46 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.